Harvard Bioscience Q2 2024 Adj. EPS $0.00 Misses $0.05 Estimate, Sales $23.097M Miss $26.400M Estimate
Portfolio Pulse from Benzinga Newsdesk
Harvard Bioscience (NASDAQ:HBIO) reported Q2 2024 earnings of $0.00 per share, missing the analyst estimate of $0.05 by 98%. Sales were $23.097M, missing the $26.400M estimate by 12.51%. Both earnings and sales showed significant declines compared to the same period last year.
August 08, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Harvard Bioscience reported Q2 2024 earnings of $0.00 per share, missing the analyst estimate of $0.05 by 98%. Sales were $23.097M, missing the $26.400M estimate by 12.51%. Both earnings and sales showed significant declines compared to the same period last year.
The significant miss on both earnings and sales estimates, along with the year-over-year declines, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100